Exact Mass: 240.13342
Exact Mass Matches: 240.13342
Found 195 metabolites which its exact mass value is equals to given mass value 240.13342
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ameltolide
C15H16N2O (240.12625659999998)
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent Same as: D02892
Imiquimod
Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment. Imiquimod does not fight the viruses that cause warts directly, however, it does help to relieve and control wart production. miquimod is also used to treat a skin condition of the face and scalp called actinic keratoses and certain types of skin cancer called superficial basal cell carcinoma. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D007155 - Immunologic Factors > D007369 - Interferon Inducers D000970 - Antineoplastic Agents C274 - Antineoplastic Agent
3-[2-(6-Methyl-2-pyridinyl)ethynyl]-2-cyclohexene-1-one O-methyloxime
C15H16N2O (240.12625659999998)
N-methyl-3-phenyl-3-(pyridin-2-yl)propanamide
C15H16N2O (240.12625659999998)
N-[3-phenyl-3-(pyridin-2-yl)propyl]formamide
C15H16N2O (240.12625659999998)
N,N-Dimethylcarbanilide
C15H16N2O (240.12625659999998)
CONFIDENCE standard compound; INTERNAL_ID 33
trans-9-hydroxy-3-methyl-8-oxo-dodec-trans-6-en-4-olide
(-)-12-hydroxyjasmonic acid methyl ester|(-)-methyl 12-hydroxyjasmonate|(1R,2R)-Methyl-5-hydroxyjasmonate|5-hydroxyjasmonic acid methyl ester|methyl (1R,2R)-5-hydroxyjasmonate|methyl (1S,2R,2Z)-2-(5-hydroxy-2-pentenyl)-3-oxo-cyclopentaneacetate
6-Norsetoclavine|8-methyl-9,10-didehydro-ergolin-8-ol|Norsetoclavin|norsetoclavine
C15H16N2O (240.12625659999998)
(2beta,3beta,5alpha,6alpha,7E)-5,6-Epoxy-2,3-dihydroxy-7-megastigmen-9-one
2-methylidenepropane-1,3-diyl 1-((Z)-2-methyl-2-butenoate) 3-isobutyrate
(1RS,9RS)-3-hydroxymethyl-8Z-(2E-pentenyliden)-2,6-dioxa-spiro<4.4>nonanol-9|(1RS,9RS)-3-hydroxymethyl-8Z-(2E-pentenyliden)-2,6-dioxa-spiro[4.4]nonanol-9|9-Hydroxy-8-(2-pentenylidene)-1,6-dioxaspiro[4,4]nonane-2-methanol
methyl (2Z,4E)-3-methoxycarbonyl-2-methyl-2,4-nonadienoate
(E)-4-((rel-3R,4S,6R)-4-hydroxy-4-methyl-6-(2-oxopropyl)-tetrahydro-2H-pyran-3-yl)but-3-en-2-one|quamopyran
(6S,7R,8R,9S)-6-oxaspiro-7,8-dihydroxymegastigman-4-en-3-one|tubiflorone
6-hexyl-3-methyl-(3S,3aS,6R,6aR)-perhydrofuro[3,4-b]furan-2,4-dione
imiquimod
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D007155 - Immunologic Factors > D007369 - Interferon Inducers D000970 - Antineoplastic Agents C274 - Antineoplastic Agent
NPE_241.1335_10.3
C15H16N2O (240.12625659999998)
CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1108
NPE_241.1335_10.8
C15H16N2O (240.12625659999998)
CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1113
diethyldiallylmalonate
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1054
(6-aminonaphthalen-2-yl)-pyrrolidin-1-ylmethanone
C15H16N2O (240.12625659999998)
3-amino-N-(2,6-dimethylphenyl)benzamide
C15H16N2O (240.12625659999998)
2-[1-(2-METHYLBENZYL)-3-OXO-2-PIPERAZINYL]-ACETIC ACID
C15H16N2O (240.12625659999998)
8-(P-TOLYL)-2,3,4,5-TETRAHYDROPYRIDO[3,2-F][1,4]OXAZEPINE
C15H16N2O (240.12625659999998)
METHYL 7-(3-HYDROXY-5-OXOCYCLOPENT-1-EN-1-YL)HEPTANOATE
1-butyl-2,3-dimethylimidazolium tetrafluoroborate
C9H17BF4N2 (240.14208399999998)
3-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-4-yl)phenol
C15H16N2O (240.12625659999998)
4-AMINO-N-(1-PHENYLETHYL)BENZAMIDE
C15H16N2O (240.12625659999998)
METHYL (R)-(+)-3-HYDROXY-5-OXO-1-CYCLOPENTENE-1-HEPTANOATE
3-[(2,4-Dimethyl-1-penten-3-yl)oxy]phthalonitrile
C15H16N2O (240.12625659999998)
Furan-2-ylmethyl-[2-(1H-indol-3-yl)-ethyl]-amine
C15H16N2O (240.12625659999998)
2-{1-[(5-METHYL-2-FURYL)METHYL]-3-OXO-2-PIPERAZINYL}ACETIC ACID
C15H16N2O (240.12625659999998)
4-[4-(TERT-BUTYL)PHENOXY]ANILINE HYDROCHLORIDE
C15H16N2O (240.12625659999998)
3-(2-METHOXYETHYL)PIPERIDINE HYDROCHLORIDE
C15H16N2O (240.12625659999998)
4-(4-FLUORO-2-NITROPHENYL)MORPHOLINE
C15H16N2O (240.12625659999998)
3-oxo-4-(1,3,3-trimethylindol-2-ylidene)butanenitrile
C15H16N2O (240.12625659999998)
1-((BENZO[D]THIAZOL-2-YL)METHYL)HYDRAZINE
C15H16N2O (240.12625659999998)
6-benzyl-5,6,7,8-tetrahydro-1,6-naphthyridin-2(1H)-one
C15H16N2O (240.12625659999998)
2-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]pyridin-3-amine
C15H16N2O (240.12625659999998)
5,5-dimethyl-2-naphthalen-1-yl-1,3,2-dioxaborinane
C15H17BO2 (240.13215320000003)
2-(2,4-DIBROMO-6-METHYLPHENOXY)ACETIC ACID
C15H16N2O (240.12625659999998)
1-(2-METHOXYETHYL)-3-PYRROLIDINYL]METHANOL
C15H16N2O (240.12625659999998)
6-Benzyl-5,6,7,8-tetrahydro-2,6-naphthyridin-1(2H)-one
C15H16N2O (240.12625659999998)
5-CHLORO-2,4-DIMETHOXY-BENZENESULFONYL CHLORIDE
C15H16N2O (240.12625659999998)
2-AMINO-6-METHYL-N-(O-TOLYL)BENZAMIDE
C15H16N2O (240.12625659999998)
N-[3-(Benzylamino)phenyl]acetamide
C15H16N2O (240.12625659999998)
1,3-Diisopropylimidazolium tetrafluoroborate
C9H17BF4N2 (240.14208399999998)
β-Phenylhydrocinnamic acid hydrazide
C15H16N2O (240.12625659999998)
(S)-TERT-BUTYL (1-(5-FLUOROPYRIDIN-2-YL)ETHYL)CARBAMATE
C12H17FN2O2 (240.12739940000003)
1-ACETYL-1,2,3,4-TETRAHYDRO-QUINOLINE-6-SULFONYL CHLORIDE
C15H16N2O (240.12625659999998)
(4-Propyl-4-biphenylyl)boronic acid
C15H17BO2 (240.13215320000003)
TERT-BUTYL 4-(5-CHLORO-1H-PYRROLO[2,3-B]PYRIDIN-4-YL)PIPERAZINE-1-CARBOXYLATE
C15H16N2O (240.12625659999998)
Benmoxin
C15H16N2O (240.12625659999998)
C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
Propanedioic acid,2-(2-cyclohexen-1-yl)-, 1,3-diethyl ester
PIPERIDIN-4-YL-QUINOLIN-3-YL-METHANONE
C15H16N2O (240.12625659999998)
1-Methyl-3-pentylimidazolium Tetrafluoroborate
C9H17BF4N2 (240.14208399999998)
11b-methyl-2,5,6,11-tetrahydro-1H-pyrrolo[5,1-a]$b-carbolin-3-one
C15H16N2O (240.12625659999998)
methyl 7-[(3S)-3-hydroxy-5-oxocyclopenten-1-yl]heptanoate
2-amino-N-(1-phenylethyl)benzamide
C15H16N2O (240.12625659999998)
Buterazine
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
2-[1-(3-METHYLBENZYL)-3-OXO-2-PIPERAZINYL]-ACETIC ACID
C15H16N2O (240.12625659999998)
3-Fluoro-4-[2-(4-morpholinyl)ethoxy]phenylamine
C12H17FN2O2 (240.12739940000003)
Ronopterin
C9H16N6O2 (240.13346760000002)
C471 - Enzyme Inhibitor > C29574 - Nitric Oxide Synthase Inhibitor
3-[2-(6-Methyl-2-pyridinyl)ethynyl]-2-cyclohexene-1-one O-methyloxime
C15H16N2O (240.12625659999998)
ABP688 is a high affinity human mGluR5 antagonist with anKi of 1.7 nM. Radioisotope-labeled ABP688 can be used as a PET tracer for clinical imaging of the mGlu5 receptor[1].
4-propan-2-yl-N-(3-pyridinyl)benzamide
C15H16N2O (240.12625659999998)
3-(1-ethyl-5-methyl-1H-pyrazol-4-yl)-1-phenyl-2-propen-1-one
C15H16N2O (240.12625659999998)
Decarbamoyl-alpha-dihydrosaxitoxin
C9H16N6O2 (240.13346760000002)
2-[3-(2-Cyanopropan-2-yl)-5-formylphenyl]-2-methylpropanenitrile
C15H16N2O (240.12625659999998)
(2R)-2-phenyl-N-pyridin-4-ylbutanamide
C15H16N2O (240.12625659999998)
(12bs)-1,2,3,4,12,12b-Hexahydroindolo[2,3-A]quinolizin-7(6h)-One
C15H16N2O (240.12625659999998)
Ameltolide
C15H16N2O (240.12625659999998)
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent Same as: D02892
1-(6,8-Dimethyl-2,3-dihydropyrrolo[2,3-g]quinolin-1-yl)ethanone
C15H16N2O (240.12625659999998)
3-[(3aS,4S,5R,7aS)-5-hydroxy-7a-methyl-1,5-dioxo-octahydroinden-4-yl]propanoic acid
2-[(6R)-6-hydroxy-6-methyl-5-oxooctyl]-2H-furan-5-one
N-Ethylharmine
C15H16N2O (240.12625659999998)
A member of the class of beta-carbolines that is 9H-beta-carboline substituted by a ethyl group at position 9, methoxy group at position 7 and a methyl group at position 1. It is semisynthetic derivative of harmine and has been shown to exhibit significant anti-HIV activity.
4-phenyl-N-(2-pyridinyl)butanamide
C15H16N2O (240.12625659999998)
3-oxo-3-phenyl-2-(3,4,5,6-tetrahydro-2H-azepin-7-yl)propanenitrile
C15H16N2O (240.12625659999998)
1-Methyl-3-propyl-1H-pyrazole-5-carboxylic acid, TMS derivative
C11H20N2O2Si (240.12939800000004)
Methyl (1S,2R,(4A)R,8S,(8A)R)-1,2,3,5,6,7,8,(8A)-octahydro-8-hydroxy-2-methylnaphthalen-4(4A)H)-one-1-carboxylate
3-[(3aS,4S,5R,7aS)-5-hydroxy-7a-methyl-1-oxo-octahydroinden-4-yl]propanoic acid
A dioxo monocarboxylic acid that consists of hydrindane bearing oxo and hydroxy substituents at positions 1 and 5 respectively as well as a 2-carboxyethyl substituent at position 4 (the 3aS,4S,5R,7aS diastereomer).
1-(2-phenylethyl)-6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one
C15H16N2O (240.12625659999998)
2-[(3s,5r)-5-hexyl-2-oxooxolan-3-yl]prop-2-enoic acid
(3z,4s,5r,7r)-7-(hydroxymethyl)-3-[(2e)-pent-2-en-1-ylidene]-1,6-dioxaspiro[4.4]nonan-4-ol
(1s,5s,8s)-8-hydroxy-8-[(1e)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-3-one
(5s)-5-(6-hydroxy-6-methyl-5-oxooctyl)-5h-furan-2-one
(4-methylidene-5-oxooxolan-3-yl)methyl 5-methylhexanoate
(3as,4r,10s,10as)-4-(hydroxymethyl)-2,6-diimino-octahydropyrrolo[1,2-c]purin-10-ol
C9H16N6O2 (240.13346760000002)
1,4-dimethyl 2-(hex-1-en-1-yl)-3-methylbut-2-enedioate
1-(1-hydroxy-2-methoxyethyl)-4-methoxy-beta-carboline
C15H16N2O (240.12625659999998)
{"Ingredient_id": "HBIN000435","Ingredient_name": "1-(1-hydroxy-2-methoxyethyl)-4-methoxy-beta-carboline","Alias": "NA","Ingredient_formula": "C15H16N2O","Ingredient_Smile": "NA","Ingredient_weight": "272.303","OB_score": "NA","CAS_id": "89915-40-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9714","PubChem_id": "NA","DrugBank_id": "NA"}
13-carboxy-blumenol c
{"Ingredient_id": "HBIN001151","Ingredient_name": "13-carboxy-blumenol c","Alias": "NA","Ingredient_formula": "C13H20O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3165","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
apocynol b
{"Ingredient_id": "HBIN016507","Ingredient_name": "apocynol b","Alias": "NA","Ingredient_formula": "C13H20O4","Ingredient_Smile": "CC(C=CC1(C(=CC(=O)CC1(C)C)CO)O)O","Ingredient_weight": "240.29 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1528","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10977562","DrugBank_id": "NA"}
4,5-dihydroxy-3-(1-hydroxyhex-4-en-1-yl)-2,5-dimethylcyclopent-2-en-1-one
(4s,5r,9s)-9-acetyl-4,6,6-trimethyl-1,8-dioxaspiro[4.5]decan-2-one
5-[5-(buta-1,3-dien-1-yl)-4-hydroxyoxolan-3-yl]pent-4-ene-2,3-diol
4-(2-methylpropyl)pyrrolo[2,3-c]quinolin-3-ol
C15H16N2O (240.12625659999998)
(5s)-5-(6-hydroxy-6-methyl-7-oxooctyl)-5h-furan-2-one
(3as,4r,10r,10as)-4-(hydroxymethyl)-2,6-diimino-octahydropyrrolo[1,2-c]purin-10-ol
C9H16N6O2 (240.13346760000002)
7-(hydroxymethyl)-3-(pent-2-en-1-ylidene)-1,6-dioxaspiro[4.4]nonan-4-ol
8-hydroxy-8-(3-hydroxybut-1-en-1-yl)-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-3-one
(3z,4s,5s,7r)-7-(hydroxymethyl)-3-[(2e)-pent-2-en-1-ylidene]-1,6-dioxaspiro[4.4]nonan-4-ol
3-butyl-1h-pyrazolo[1,5-b]isoquinolin-9-one
C15H16N2O (240.12625659999998)
(z)-n-(2-{5-[(1e)-3-methylbuta-1,3-dien-1-yl]-1h-indol-3-yl}ethylidene)hydroxylamine
C15H16N2O (240.12625659999998)
(4s)-4-[(1e,3s)-3,4-dihydroxybut-1-en-1-yl]-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one
6-(2-butoxyethyl)-4-hydroxy-3,5-dimethylpyran-2-one
(1r,5r,8r)-8-hydroxy-8-[(1e,3r)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-3-one
4-hydroxy-4-[3-(1-hydroxyethyl)oxiran-2-yl]-3,5,5-trimethylcyclohex-2-en-1-one
(3z,4r,5r,7s)-7-(hydroxymethyl)-3-[(2e)-pent-2-en-1-ylidene]-1,6-dioxaspiro[4.4]nonan-4-ol
4-hydroxy-6-(5-hydroxy-5-methylhexyl)-3-methylpyran-2-one
(1r,5r,8r)-8-hydroxy-8-[(1e,3s)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-3-one
1-{5-[(1r,2s)-1,2-dihydroxyheptyl]furan-2-yl}ethanone
(1r,5r,8s)-8-hydroxy-8-[(1e,3s)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-3-one
(2e,6e)-10-methoxy-3,7-dimethyl-10-oxodeca-2,6-dienoic acid
4-(3-oxobutan-2-yl)-2-(sec-butyl)-4,5-dihydrofuran-3-carboxylic acid
4-hydroxy-6-[(2s)-2-hydroxyheptyl]-3-methylpyran-2-one
(3s,3as,4s,7r,11as)-4,7-dihydroxy-3-methyl-3h,3ah,4h,5h,6h,7h,8h,9h,11ah-cyclodeca[b]furan-2-one
1-[4-(2-hydroxyethyl)phenoxy]-3-methylbutane-2,3-diol
2-[(3r,5r)-5-hexyl-2-oxooxolan-3-yl]prop-2-enoic acid
1,4-dimethyl (2z)-2-[(1e)-hex-1-en-1-yl]-3-methylbut-2-enedioate
(2r,3r,4e)-5-[(3s,4r,5s)-5-[(1e)-buta-1,3-dien-1-yl]-4-hydroxyoxolan-3-yl]pent-4-ene-2,3-diol
(4s)-4-hydroxy-4-[(2s,3r)-3-[(1s)-1-hydroxyethyl]oxiran-2-yl]-3,5,5-trimethylcyclohex-2-en-1-one
(4s)-4-[(2r)-3-oxobutan-2-yl]-2-(sec-butyl)-4,5-dihydrofuran-3-carboxylic acid
1-[(3r,6r,7s)-1,7-dihydroxy-3,6-dimethyl-4-oxatricyclo[4.3.1.0³,⁷]decan-9-yl]ethanone
8-hydroxy-8-[(1e)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-3-one
6-hexyl-3-methyl-tetrahydrofuro[3,4-b]furan-2,4-dione
1-[5-(1-methoxypent-4-en-1-yl)furan-2-yl]propane-1,2-diol
3-[2-(2-methylpropyl)-1,3-oxazol-5-yl]-1h-indole
C15H16N2O (240.12625659999998)
(4s,5s)-4,5-dihydroxy-3-[(1r,4e)-1-hydroxyhex-4-en-1-yl]-2,5-dimethylcyclopent-2-en-1-one
4-(3,4-dihydroxybut-1-en-1-yl)-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one
(4s)-4-hydroxy-4-[(2r,3s)-3-[(1r)-1-hydroxyethyl]oxiran-2-yl]-3,5,5-trimethylcyclohex-2-en-1-one
3-[(3-methylimidazol-4-yl)methyl]-1-phenylbut-3-en-1-one
C15H16N2O (240.12625659999998)